Report post
Moderna's stock price has experienced significant volatility, with reports of crashes and subsequent recoveries. The company has hiked its forecast for the Covid-19 vaccine, which has positively impacted its share price. Despite a steep decline of 85% at some point, there have been signs of recovery. Moderna also plans a stock buyback, indicating confidence in its future. Investors should closely monitor these developments to make informed decisions.

The World's Leading Crypto Trading Platform

Get my welcome gifts